Skip to content
OpenCapital
Get started

Biofrontera Inc. BFRI Q4 2024 Annual earnings

Reported March 21, 2025 · Before market open

Revenue$12.6MBeat by $2.1MDiluted EPS-$2.33Miss by $2.35
Revenue estimate$10.5M
EPS estimate$0.02

Next report

Aug 12, 2026 (in a month)
Revenue estimate$9.5M
EPS estimate-$0.11

Versus estimates

Revenue

Q1 2026$10.1MMiss by $166.0KQ4 2025$17.1MBeat by $950.0KQ3 2025$7.0MMiss by $9.2MQ2 2025$9.0MMiss by $520.0KQ1 2025$8.6MMiss by $2.0M
Q4 2024$12.6MBeat by $2.1M

Diluted EPS

Q1 2026-$0.41Miss by $0.23Q4 2025$0.50Beat by $0.21Q3 2025-$0.59Beat by $0.01Q2 2025-$0.57Miss by $0.12Q1 2025-$0.47Miss by $0.33
Q4 2024-$2.33Miss by $2.35

Ask the moment Biofrontera Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Biofrontera Inc. report Q4 2024 earnings?
Biofrontera Inc. (BFRI) reported Q4 2024 earnings on March 21, 2025 before market open.
What were Biofrontera Inc.'s Q4 2024 revenue and EPS?
Biofrontera Inc. reported revenue of $12.6M and diluted EPS of $-2.33 for Q4 2024.
Did Biofrontera Inc. beat estimates in Q4 2024?
Revenue beat the consensus estimate of $10.5M by $2.1M. EPS missed the consensus estimate of $0.02 by $2.35.
Where can I find Biofrontera Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001493152-25-011052) directly on SEC EDGAR. The filing index links above go to sec.gov.